Travere therapeutics director Roy Baynes sells $209,925 stock

Travere therapeutics CEO Eric Dube sells $988,875 in shares

Investing.com · News 17m ago

Symbotic director Todd Krasnow sells $115,217 in company stock

Investing.com · News 18m ago

Olympics-LA28 plans citywide Cultural Olympiad built around local artists, communities

Investing.com · News 18m ago

US stock futures edge lower after Wall St hits record highs on Iran hopes

Investing.com · News 18m ago

US, Iran Weigh Potential Deal, Trump Says ‘We Won’

Bloomberg · Markets Video 19m ago

Travere therapeutics chief legal officer sells $1.09m in company stock

Investing.com · News 20m ago

Arm's Recent Pivot Will Power a New $15 Billion Market

NASDAQ · Markets 21m ago

Singapore Bourse May Extend Wednesday's Gains

NASDAQ · Markets 24m ago

Thursday's big stock stories: What’s likely to move the market in the next trading session

CNBC · Economy 25m ago

Chinese Creditors Turn to Hong Kong Courts to Enforce Rulings

Bloomberg · Markets 25m ago